These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26964672)

  • 1. Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.
    Chen R; Xiao J; Ni Y; Xu HF; Zheng M; Tong X; Zhang TT; Liao C; Tang WJ
    Bioorg Med Chem; 2016 Apr; 24(8):1741-8. PubMed ID: 26964672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
    Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C
    Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
    Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and in vitro hMAO-B inhibitory evaluation of some 1-methyl-3,5-diphenyl-4,5-dihydro-1H-pyrazoles.
    Fioravanti R; Desideri N; Biava M; Proietti Monaco L; Grammatica L; Yáñez M
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5128-30. PubMed ID: 23927971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
    J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
    Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and bioevalucation of novel 2,3-dihydro-1H-inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline.
    Xiao X; Zhang XX; Zhan MM; Cheng K; Li S; Xie Z; Liao C
    Eur J Med Chem; 2018 Feb; 145():588-593. PubMed ID: 29339253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues.
    Evranos-Aksoz B; Ucar G; Yelekci K
    Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
    Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.
    Tong X; Chen R; Zhang TT; Han Y; Tang WJ; Liu XH
    Bioorg Med Chem; 2015 Feb; 23(3):515-25. PubMed ID: 25541201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
    Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
    Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
    Liu L; Chen Y; Zeng RF; Liu Y; Xie SS; Lan JS; Ding Y; Yang YT; Yang J; Zhang T
    Bioorg Chem; 2021 Apr; 109():104685. PubMed ID: 33640631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
    He X; Chen YY; Shi JB; Tang WJ; Pan ZX; Dong ZQ; Song BA; Li J; Liu XH
    Bioorg Med Chem; 2014 Jul; 22(14):3732-8. PubMed ID: 24856304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
    Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
    Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors.
    Desideri N; Proietti Monaco L; Fioravanti R; Biava M; Yáñez M; Alcaro S; Ortuso F
    Eur J Med Chem; 2016 Jul; 117():292-300. PubMed ID: 27135371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.
    Evranos-Aksöz B; Baysal İ; Yabanoğlu-Çiftçi S; Djikic T; Yelekçi K; Uçar G; Ertan R
    Arch Pharm (Weinheim); 2015 Oct; 348(10):743-56. PubMed ID: 26293971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation.
    Kong H; Meng X; Hou R; Yang X; Han J; Xie Z; Duan Y; Liao C
    Bioorg Med Chem Lett; 2021 Jul; 43():128051. PubMed ID: 33887441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
    Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Yáñez M; Vitali A; Ortuso F; Alcaro S
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6479-82. PubMed ID: 20934874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.